← Back to all trials
Not Yet Recruiting
NCT05667324
Septorhinoplasty Post-operative Pain Control With SPG Nerve Block
Conditions: Deviated Nasal Septum
Sex: All
Ages: 18 Years – 80 Years
Phase: PHASE4
Enrollment: 120
Sponsor: University of Florida
Summary
Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery.
This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery.
It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.
Eligibility Criteria
Inclusion Criteria:Patient presenting for open or endoscopic septorhinoplastyAge 18-80Normal oral food and water intake before surgeryASA physical classification 1-3Exclusion Criteria:Refusal to consentPatients without a cellular phone or who are unable to accept text messagesAllergy to opioid narcoticsASA physical classification of 4 or higherPatient requires other surgery in addition to septorhinoplastyAge > 80 or <18Any underlying chronic pain condition or ongoing opioid use over the preceding 3 monthsPresence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.Pregnant women
Source: ClinicalTrials.gov (NCT05667324). StuddyBuddy aggregates publicly available trial information.